Protein oxidation and DNA repair inhibition by 6-thioguanine and UVA radiation

Journal of Investigative Dermatology

Volumn 134, Issue 5, 2014, Pages 1408-1417

  Gueranger, Quentin ^a   Li, Feng ^a   Peacock, Matthew ^a   Larnicol Fery, Annabel ^b   Brem, Reto ^a   Macpherson, Peter ^a   Egly, Jean Marc ^b   Karran, Peter ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; PHOTOSENSITIZING AGENT; PROTEOME; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; TIOGUANINE; CYSTEINE; DNA GLYCOSYLTRANSFERASE; KU ANTIGEN; MERCAPTOPURINE; MYH PROTEIN; OGG 1 PROTEIN; PROTEIN; RPA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DNA STRAND BREAKAGE; EXCISION REPAIR; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; PROTEIN CARBONYLATION; PROTEIN METABOLISM; SKIN CARCINOGENESIS; SUNLIGHT; ULTRAVIOLET A RADIATION; CELL CULTURE; COMET ASSAY; DNA CROSS LINKING; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GEL ELECTROPHORESIS; IN VITRO STUDY; MASS SPECTROMETRY; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN OXIDATION; SKIN; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; CRICETINAE; DNA END-JOINING REPAIR; DNA GLYCOSYLASES; DNA HELICASES; DNA REPAIR; FIBROBLASTS; HELA CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA; OXIDATION-REDUCTION; PHOTOSENSITIVITY DISORDERS; PROTEOME; RISK FACTORS; SKIN NEOPLASMS; THIOGUANINE; ULTRAVIOLET RAYS;

EID: 84900838270     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.509     Document Type: Article

References (58)

1. Anderson RR, Parrish JA (1981) The optics of human skin. J Invest Dermatol 77:13-9
2. Baty JW, Hampton MB, Winterbourn CC (2002) Detection of oxidant sensitive thiol proteins by fluorescence labeling and two-dimensional electrophoresis. Proteomics 2:1261-6
3. Bennett SM, Neher TM, Shatilla A et al. (2009) Molecular analysis of Ku redox regulation. BMC Mol Biol 10:86
4. Bravard A, Vacher M, Gouget B et al. (2006) Redox regulation of human OGG1 activity in response to cellular oxidative stress. Mol Cell Biol 26:7430-6
5. Brem R, Daehn I, Karran P (2011) Efficient DNA interstrand crosslinking by 6-Thioguanine and UVA radiation. DNA Repair 10:869-76
6. Brem R, Karran P (2012) Multiple forms of DNA damage caused by UVA photoactivation of DNA 6-Thioguanine. Photochem Photobiol 88:5-13
7. Brem R, Li F, Montaner B et al. (2010) DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation. Oncogene 29:3953-63
8. Cadet J, Sage E, Douki T (2005) Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 571:3-17
9. Cooke MS, Duarte TL, Cooper D et al. (2008) Combination of azathioprine and UVA irradiation is a major source of cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine. DNA Repair 7:1982-9
10. Daehn I, Karran P (2008) Immune effector cells produce lethal DNA damage in cells treated with a thiopurine. Cancer Res 69:2393-9
11. Daly MJ (2009) A new perspective on radiation resistance based on Deinococcus radiodurans. Nat Rev Microbiol 7:237-45
12. Davies MJ (2003) Singlet oxygen-mediated damage to proteins and its consequences. Biohem Biophys Res Commun 305:761-70
13. Douki T, Reynaud-Angelin A, Cadet J et al. (2003) Bipyrimidine photoproducts rather than oxidative DNA lesions are the main type of DNA damage involved in the genotoxic effect of solar UVA radiation. Biochemistry 42:9221-6
14. Drucker AM, Rosen CF (2011) Drug-induced photosensitivity: Culprit drugs, management and prevention. Drug Saf 34:821-37
15. Dummer R, Rinderknecht J, Goldinger SM (2012) Ultraviolet A and photosensitivity during vemurafenib therapy. N Engl J Med 366:480-1
16. Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681-91
17. Gelot P, Dutarte H, Khammari A et al. (2013) Vemurafenib: An unusual UVAinduced photosensitivity. Exp Dermatol 22:290-301
18. Ghissassi FE, Baan R, Straif K et al. (2009) A review of human carcinogens-Part D: Radiation. Lancet Oncol 10:751-2
19. Harwood CA, Attard NR, O'Donovan P et al. (2008) PTCH mutations in basal cell carcinomas from azathioprine-Treated organ transplant recipients. Br J Cancer 99:1276-84
20. Hemmens VJ, Moore DE (1986) Photochemical sensitization by azathioprine and its metabolites-I. 6-Mercaptopurine. Photochem Photobiol 43:247-55
21. Hennequin C, Giocanti N, Balosso J et al. (1994) Interaction of ionizing radiation with the topoisomerase poison camptothecin in growing V-79 and HeLa cells. Cancer Res 54:1720-8
22. Hill JW, Evans MK (2006) Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res 34:1620-32
23. Hofbauer GFL, Straub G, Dziunycz P et al. (2011) Switching from azathioprine to mycophenolate mofetil improves skin photosensitivity in kidney transplant recipients. Am J Transplant 12:218-25
24. Jackson SP (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687-96
25. Karran P, Attard N (2008) Thiopurines in current medical practice: Molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer 8:24-36
26. Kawanishi S, Murata M (2006) Mechanism of DNA damage induced by bromate differs from general types of oxidative stress. Toxicology 221:172-8
27. Krisko A, Leroy M, Radman M et al. (2011) Extreme anti-oxidant protection against ionizing radiation in bdelloid rotifers. Proc Natl Acad Sci USA 109:2354-7
28. Krisko A, Radman M (2010) Protein damage and death by radiation in Escherichia coli and Deinococcus radiodurans. Proc Natl Acad Sci USA 107:14373-7
29. Laine JP, Mocquet V, Egly JM (2006) TFIIH enzymatic activities in transcription and nucleotide excision repair. Methods Enzymol 408:246-63
30. Leonard SE, Reddie KG, Caroll KS (2009) Mining the thiol proteome for sulfenic acid modifications reveals new targets for oxidation in cells. ACS Chem Biol 4:783-99
31. Lhiaubet-Vallet V, Bosca F, Miranda MA (2009) Photosensitized DNA damage: The case for fluoroquinolones. Photochem Photobiol 85: 861-8
32. Luncsford PJ, Chang D-Y, Shi G et al. (2010) A structural hinge in eukaryotic MutY homologues mediates catalytic activity anf Rad9-Rad1-Hus1 checkpoint complex interactions. J Mol Biol 403:351-70
33. McGowan AJ, Bowie AG, O'Neill LAJ et al. (1998) The production of a reactive oxygen intermediate diring the induction of apoptosis by cytotoxic insult. Exp Cell Res 238:248-56
34. McGregor JM, Berkhout RJM, Rozycka M et al. (1997) P53 mutations implicate sunlight in post-Transplant skin cancer irrespective of human papillomavirus status. Oncogene 15:1773-40
35. McKinlay AF, Diffey BL (1987) A reference action spectrum for ultraviolet induced erythema in skin. CIE J 6:17-22
36. Men L, Roginskaya M, Zou Y et al. (2007) Redox-dependent formation of disulfide bonds in replication protein A. Rapid Commun Mass Spectrom 21:2743-9
37. Montaner B, O'Donovan P, Reelfs O et al. (2007) Reactive oxygen-mediated damage to a human DNA replication and repair protein. EMBO Rep 8:1074-9
38. Mouret S, Phillippe C, Gracia-Chantegrel J et al. (2010) UVA-induced cyclobutane pyrimidine dimers in DNA: A direct photochemical mechanism? Org Biomol Chem 8:1706-11
39. Nilsen H, Rosewell I, Robins P et al. (2000) Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Mol Cell 5:1059-65
40. O'Donovan P, Perrett CM, Zhang X et al. (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309:1871-4
41. O'Driscoll M, Cerosaletti KM, Girard P-M et al. (2001) DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 8:1175-85
42. Perrett CM, Walker SL, O'Donovan P et al. (2008) Azathioprine treatment sensitizes human skin to ultraviolet A radiation. Br J Dermatol 159:198-204
43. Peyrin-Biroulet L, Khosrotehrani K, Carrat F et al. (2011) Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 141:1621-8
44. Pleasance ED, Cheetham RK, Stephens PJ et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463:191-6
45. Pogoda de la Vega U, Rettberg P, Douki T et al. (2005) Sensitivity to polychromatic UV-radiation of strains of Deinococcus radiodurans differing in their DNA repair capacity. Int J Radiat Biol 81:601-11
46. Poon HF, Abdullah L, Reed J et al. (2007) Improving image analysis in 2DGEbased redox proteomics by labeling protein carbonyl with fluorescent hydroxylamine. Biol Proced Online 9:65-72
47. Queille S, Luron L, Spatz A et al. (2007) Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UVspecific tandem CC to TT mutations in the p53 gene. Carcinogenesis 28:724-31
48. Ramiscal JAB, Brewer JD (2013) Thiopurines and risk of nonmelanoma skin cancer in inflammatory bowel disease. JAMA Dermatol 149:92-4
49. Russo MT, Luca GD, Degan P et al. (2007) Different DNA repair strategies to combat the threat from 8-oxoguanine. Mutat Res 614:69-76
50. Schafer M, Schmitz C, Horneck G (1998) High sensitivity of Deinococcus radiodurans to photodynamically-produced singlet oxygen. Int J Radiat Biol 74:249-53
51. Setshedi M, Epstein D, Winter TA et al. (2012) Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: A cohort study. J Gastroenterol Hepatol 27:385-9
52. Slade D, Radman M (2011) Oxidative stress resistance in Deinococcus radiodurans. Microbiol Mol Biol Rev 75:133-91
53. Taccioli GE, Gottlieb TM, Blunt T et al. (1994) Ku80: Product of the XRCC5 gene and its role in DNA repair and V(DJ) recombination. Science 265:1442-5
54. Taverna P, Liu L, Hanson AJ et al. (2000) Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen. Cancer Chemother Pharmacol 46:507-16
55. Tewari A, Sarkany RP, Young AR (2012) UVA1 induces cyclobutane pyrimidine dimers but not 6-4 photoproducts in human skin in vivo. J Invest Dermatol 132:394-400
56. Warren DJ, Andersen A, Slordal L (1995) Quantitation of 6-Thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy. Cancer Res 55:1670-4
57. Zahradka K, Slade D, Bailone A et al. (2006) Reassembly of shattered chromosomes in Deinococcus radiodurans. Nature 443:569-73
58. Zhang X, Jeffs G, Ren X et al. (2007) Novel DNA lesions generated by the interaction between therapeutic thiopurines and UVA light. DNA Rep 6:344-54